Clinical Trials
-
Second schizophrenia treatment discovered at Vanderbilt’s Warren Center enters phase I clinical trial
A new potential treatment for schizophrenia discovered through the Warren Center for Neuroscience Drug Discovery at Vanderbilt University has entered phase 1 clinical trials, marking the fifth WCNDD therapeutic to advance into human testing. Read MoreNov. 12, 2025
-
Diabetes discoveries: Transforming understanding and care
Prior to insulin’s introduction to the clinic in 1922, life expectancy after a type 1 diabetes diagnosis was only one to two years. Even after insulin, without the understanding and technology we have today, managing diabetes was a struggle. Read MoreMar. 7, 2024